Oncology & Cancer

Tool targets cancer-causing fusions' weak spot

Scientists at St. Jude Children's Research Hospital comprehensively characterized oncogenic fusions in pediatric cancer, providing proof-of-principle for genetic engineering-based therapies.

Biomedical technology

Scientists first in the world to regenerate diseased kidney cells

In a world first, scientists at Duke-NUS Medical School, the National Heart Center Singapore (NHCS) and colleagues in Germany have shown that regenerative therapy to restore impaired kidney function may soon be a possibility.

Oncology & Cancer

Researchers design new hydrogel for more targeted cancer treatments

University of Toronto researchers have designed a new way to grow cells in a lab that enables them to better emulate cancerous tumors. The platform—based on a type of material known as a hydrogel, a soft jelly-like substance—opens ...

Oncology & Cancer

Potential role of gas plasma in leukemia treatment

A unique collection of tissue samples donated by people with chronic myeloid leukemia was the driving force behind the discovery of a potentially major new treatment approach for drug-resistant leukemia. As published this ...

page 2 from 23